Shares of Strides Arcolab were today trading at Rs 667.60 per scrip in the morning trade on BSE, up 2.54 per cent from its previous close.

Goldman Sachs Investments Mauritius, a shareholder of Strides Arcolab, today sold 4.2 lakh shares of the drug company for Rs 36.81 crore in...

Goldman Sachs Investments Mauritius today sold 3.80 lakh shares of drug major Strides Arcolab for nearly Rs 33.4 crore in open market.

Net sales of the company however stood at Rs 150.83 crore for the quarter under consideration as against Rs 162.65 crore for the same perio...

Net sales of the company rose to Rs 161.34 crore for the first quarter, as against Rs 120.42 crore in the same period of last year.

Drug firm Strides Arcolab reported a 10.55 per cent dip in consolidated net profit to Rs 61.19 crore for the fourth quarter ended December ...

Pfizer's discussions with Strides Arcolab to acquire the latter's unit, Agila Specialties , is at a fairly advanced stage.

Strides Arcolab plans to immediately launch the product through US-headquartered firm Alvogen on a profit sharing basis.

Strides Arcolab today said it has received approval from the Canadian health regulator for antibiotic tobramycin injection used for treatin...

Drug firm Strides Arcolab today said it has rebranded its specialities division, Strides Specialties as Agila Specialties, and that it will...

Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Br...

I-bankers, acting on behalf of Strides, have signalled M&A interest on part of the promoter group for its speciality pharma and R&D units.

Strides Arcolab has announced a corporate restructuring, which will see the company create two distinct wholly-owned subsidiaries covering ...

Strides Arcolab has received its third abbreviated new drug application approval, for Fosphenytoin Injection 50mg/mL in 2 ml and 10 ml vial...

Strides Arcolab has received second abbreviated new drug application approval for Tobramycin 40 mg/ml.

Pharmaceutical company Strides Arcolab today said it has completed the acquisition of Italy-based Diaspa SpA's fermentation assets includin...

Strides Arcolab on Friday said it has inaugurated its sterile injectable facility at Compos in Rio De Janeiro, Brazil.